http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1121238-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_59e1d955a7b1560dc68cf7fd800e8fac |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
filingDate | 1998-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a02a7f41debf4347a2466f6a4d52216 |
publicationDate | 1999-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H1121238-A |
titleOfInvention | Prevention and treatment of arteriosclerosis |
abstract | (57) [Problem] To provide a novel agent for preventing or treating arteriosclerosis having a clinically sufficient effect. SOLUTION: General formula (1): (Wherein, R 1 represents a hydrogen atom or an acyl group, R 2 represents a lower alkyl group, R 3 represents a hydrogen atom or a lower alkyl group, and R 4 , R 5 , and R 6 represent a hydrogen atom, alkyl group, an alkenyl group, or an alkynyl group or an aryl group, or may form a furan ring or dihydrofuran ring R 2 and R 4 together with the oxygen atom, R 5 and R 6 Taken together may form a cycloalkyl group, or a heterocyclic group in which one or more optional methylenes on the ring of the cycloalkyl group is replaced by an oxygen, sulfur or alkyl-substituted nitrogen atom. A prophylactic / therapeutic agent for arteriosclerosis, comprising as an active ingredient the indicated compound, a possible optically active substance thereof, or a pharmaceutically acceptable salt thereof. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03018001-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0213819-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0050029-A1 |
priorityDate | 1997-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 111.